These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. Ono A, Orenstein JM, Freed EO. J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302 [Abstract] [Full Text] [Related]
28. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. Accola MA, Strack B, Göttlinger HG. J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843 [Abstract] [Full Text] [Related]
29. Tryptophan 95, an amino acid residue of the Caprine arthritis encephalitis virus vif protein which is essential for virus replication. Seroude V, Audoly G, Gluschankof P, Suzan M. Virology; 2001 Feb 15; 280(2):232-42. PubMed ID: 11162837 [Abstract] [Full Text] [Related]
30. Mutational analysis of two zinc finger motifs in HIV type 1 nucleocapsid proteins: effects on proteolytic processing of Gag precursors and particle formation. Mizuno A, Ido E, Goto T, Kuwata T, Nakai M, Hayami M. AIDS Res Hum Retroviruses; 1996 Jun 10; 12(9):793-800. PubMed ID: 8738431 [Abstract] [Full Text] [Related]
31. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. Ono A, Demirov D, Freed EO. J Virol; 2000 Jun 10; 74(11):5142-50. PubMed ID: 10799589 [Abstract] [Full Text] [Related]
34. Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1. Coren LV, Thomas JA, Chertova E, Sowder RC, Gagliardi TD, Gorelick RJ, Ott DE. J Virol; 2007 Sep 10; 81(18):10047-54. PubMed ID: 17634233 [Abstract] [Full Text] [Related]
35. Viral and cellular specificities of caprine arthritis encephalitis virus Vif protein. Seroude V, Audoly G, Gluschankof P, Suzan M. Virology; 2002 Jan 05; 292(1):156-61. PubMed ID: 11878918 [Abstract] [Full Text] [Related]
36. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. Kondo E, Mammano F, Cohen EA, Göttlinger HG. J Virol; 1995 May 05; 69(5):2759-64. PubMed ID: 7707498 [Abstract] [Full Text] [Related]
37. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. Fouchier RA, Simon JH, Jaffe AB, Malim MH. J Virol; 1996 Dec 05; 70(12):8263-9. PubMed ID: 8970945 [Abstract] [Full Text] [Related]
38. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation. Joshi A, Nagashima K, Freed EO. J Virol; 2006 Aug 05; 80(16):7939-51. PubMed ID: 16873251 [Abstract] [Full Text] [Related]
39. Morphopoietic determinants of HIV-1 Gag particles assembled in baculovirus-infected cells. Gay B, Tournier J, Chazal N, Carrière C, Boulanger P. Virology; 1998 Aug 01; 247(2):160-9. PubMed ID: 9705909 [Abstract] [Full Text] [Related]
40. Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure. Henzler T, Harmache A, Herrmann H, Spring H, Suzan M, Audoly G, Panek T, Bosch V. J Gen Virol; 2001 Mar 01; 82(Pt 3):561-573. PubMed ID: 11172097 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]